Investigating Determinants of COVID-19 outcomes amongst South Asians in India and U.K
Not Applicable
- Registration Number
- CTRI/2021/07/035068
- Lead Sponsor
- Department of Biotechnology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All South Asian men and women who are already participants of our existing population cohorts (LOLIPOP, iHealth-T2D, and GHRU surveillance studies) will be eligible to take part in this research. All study participants are >18 years old and have consented to recontact for research as part of enrolment to the respective population study.
Exclusion Criteria
Participants who have currently acute illness, or who are unable to provide consent will be excluded from the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the incidence of COVID-19 amongst participants of our established prospective population studies in India and the UK through serological testing, and linkage to electronic health registries. <br/ ><br>Timepoint: 12 months
- Secondary Outcome Measures
Name Time Method To determine the major risk factors for infection with SARS-CoV2 severe prolonged COVID-19 amongst South Asians To determine the social behavioral & environmental factors that underly susceptibility to COVID 19 in Asian populations and whether these known risk factors explain the high risk of COVID- 19 in Asians by comparing our results in South Asians with equivalent data for Europeans To report on vaccine hesitancy in South Asians and the main reasons for this <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: 12 Months